长非编码RNAANRIL通过miR-191-5p/SATB1轴调节性结肠炎中的炎症因子表达
Ke-Qi Yu1, Chuan-Fei Li1, Lu Ye1
1Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong, Chongqing, 400010, China.
Inflammation
|November 20, 2023
概括
长非编码RNAANRIL通过通过miR-191-5p/SATB1通路抑制IL-6和TNF-α来抑制性结肠炎 (UC) 的进展. 较低的ANRIL水平与UC严重程度相关.
科学领域:
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种具有显著发病率的炎症性肠病.
- 导致UC病变的精确分子机制尚不完全理解.
- 在UC患者中观察到长非编码RNA (lncRNA) ANRIL的减少表达,但其功能作用尚不清楚.
研究的目的:
- 阐明 lncRNA ANRIL 影响性结肠炎的机制.
- 研究ANRIL/miR-191-5p/SATB1轴在调节UC中的关键炎性细胞因子中的作用.
主要方法:
- 在UC患者组织中分析ANRIL,IL-6和TNF-α的表达.
- 使用LPS治疗的FHC进行体外研究,以评估ANRIL对细胞因子产生的影响.
- 双 luciferase 记者测定证实ANRIL,miR-191-5p和SATB1.1.p之间的直接相互作用.
- 使用DSS诱导的大肠炎小鼠模型进行体内研究,以评估ANRIL对疾病进展的影响.
主要成果:
- 在UC患者中,ANRIL的表达显著下降,与疾病严重程度相关.
- 降低ANRIL的调节导致IL-6和TNF-α表达在体外增加.
- ANRIL直接向并抑制miR-191-5p,从而导致SATB1的上调.
- 过度表达miR-191-5p可以逆转ANRIL对IL-6和TNF-α的抑制作用.
- 在小鼠中,ANRIL缺乏症加剧了DSS诱导的大肠炎.
结论:
- 通过调节miR-191-5p/SATB1轴,ANRIL作为UC炎症的关键抑制剂.
- 这项研究确定了一种参与UC进展的新型分子途径.
- ANRIL/miR-191-5p/SATB1轴代表了性结肠炎的潜在治疗.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


